Scotland · NHS Scotland MSAN
Hyoscine hydrobromide (Scopoderm®) 1.5mg patches
MSAN(2023)31 · Level 2 · issued 06 Oct 2023
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Hyoscine hydrobromide (Scopoderm®) 1.5mg patches are in limited supply until w/c 1st January | Limited supply | w/c 1st January |
| 2. Alternative formulations of hyoscine hydrobromide remain available and will be able to the | Available | — |
| 3. Glycopyrronium tablets and liquid remain available and will be able to the support an increase in | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.